A new class of drugs, Lu-PSMA-617, track down i prostate cancers resistant achieving good success and extending the life of patients.
This was declared by an international team of researchers including Professor Johann de Bono, Professor of Experimental Cancer Medicine at the Institute of Cancer Research, London, and Medical Oncologist Advisor at the Royal Marsden NHS Foundation Trust, and Professor Ken Herrmann, Director of the Nuclear Medicine Clinic at the University Hospital from Essen, Germany.
Read Also
- A doctor who was leaving surgery is the victim of a violent lock-in at the Vitacura service center Nov 24, 2022
- Brentford achieves promotion to Premier League after 74 years May 30, 2021
- If you have doubts about going to a party or an event, ask yourself these three questions beforehand May 28, 2021
- Gunter Rave Reveals They Already Scheduled Their COVID-19 Vaccination: “I’m Excited” Jun 30, 2021
- How does covid-19 affect sexual life? May 28, 2021
- Heatwaves and Covid-19: Health authorities estimate the excess number of deaths in France this summer at 10,420 Nov 22, 2022
- COVID-19 can infect children, some even severely Aug 25, 2021